Correction of Cancer-related Coagulopathy With Novel Oral Anticoagulant (Edoxaban)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Correction of Cancer-related Coagulopathy With Novel Oral Anticoagulant (Edoxaban) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

UnknownPhase 2/3

NCT03570281

Edoxaban for the Treatment of Coagulopathy in Patients With Active Cancer and Acute Ischemic Stroke: a Pilot Study. (ENC…

Purpose: Cancer-related hypercoagulability plays an important role in the development of cancer-related stroke. With rapidly aging population and increasing can…

South Korea40 participantsStarted 2018-06-15

Treatment: Edoxaban, Enoxaparin